Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Feb 1.

Published in final edited form as: Kidney Int. 2018 Dec 24;95(2):439–446. doi: 10.1016/j.kint.2018.09.019

Figure 1. — Adjusted Point Estimates And Confidence Intervals Of Plasma Endostatin For The Kidney Outcome In ACCORD And BioMe Biobank

In ACCORD: 1^st Quartile was <32.3 ng/ml; 2^nd quartile was 32.4–38.2 ng/ml; 3^rd quartile was 38.3–47.6 ng/ml and 4^th quartile was >47.7 ng/ml

In BioMe Biobank: 1^st Quartile was <30.5 ng/ml; 2^nd quartile was 30.6–38.7 ng/ml; 3^rd quartile was 38.7–48.6 ng/ml and 4^th quartile was >48.7 ng/ml

Odds ratios were used in ACCORD (case-control design) and hazards ratios in BioMe (cohort study).